Status:
COMPLETED
Nalox-Comm: Naloxone Communication Training for Pharmacists
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Naloxone
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
This is a pilot Randomized Controlled Trial (RCT) in which 120 pharmacists will be randomized to an experimental or control group and data on naloxone dispensing and secondary outcomes will be collect...
Detailed Description
This is a prospective pilot RCT that will evaluate the impact of naloxone communication training (Nalox-Comm) on 120 pharmacists' naloxone dispensing behaviors (primary outcome). Data will be collecte...
Eligibility Criteria
Inclusion
- currently work at a pharmacy that stocks naloxone;
- currently work at a rural community pharmacy;
- are at least 18 years of age; and
- speak English.
Exclusion
- Non-staff pharmacists such as pharmacy "floaters" or fill-in pharmacists will not be eligible to participate.
Key Trial Info
Start Date :
July 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04677387
Start Date
July 1 2021
End Date
July 31 2023
Last Update
June 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina at Chapel Hill (Asheville campus)
Asheville, North Carolina, United States, 28804